Benjia Liang
Overview
Explore the profile of Benjia Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu J, E T, Zhou M, Niu J, Wang J, Miao R, et al.
Am J Cancer Res
. 2024 Jun;
14(5):2608-2625.
PMID: 38859847
The immune escape of colon cancer and its role in the response to immunotherapies such as PD-1/PD-L1 checkpoint inhibitors have long been of great interest. The positive outcomes of immunotherapy...
2.
Sun Y, Li Z, Tian Y, Gao C, Liang B, Cao S, et al.
BMC Gastroenterol
. 2023 Apr;
23(1):117.
PMID: 37041468
Objective: To evaluate the multiple factors influencing the survival of elderly patients with locally advanced gastric cancer (LAGC) and develop and validate the novel nomograms for predicting the survival. Methods:...
3.
Dodagatta-Marri E, Ma H, Liang B, Li J, Meyer D, Chen S, et al.
Cell Rep
. 2021 Jul;
36(1):109309.
PMID: 34233193
αvβ8 integrin, a key activator of transforming growth factor β (TGF-β), inhibits anti-tumor immunity. We show that a potent blocking monoclonal antibody against αvβ8 (ADWA-11) causes growth suppression or complete...
4.
Zhou M, Niu J, Wang J, Gao H, Shahbaz M, Niu Z, et al.
J Cancer
. 2020 Apr;
11(13):3803-3815.
PMID: 32328185
Integrin αvβ8 expressed on tumor cells executes crucial regulatory functions during cell adhesion in the tumor microenvironment and supports the activation of TGF-β1. This study aimed to investigate the expression...
5.
Liang B, Li L, Miao R, Wang J, Chen Y, Li Z, et al.
Cancer Invest
. 2019 Apr;
37(3):174-184.
PMID: 30982362
As important factors in the tumor microenvironment, interleukin-6 (IL-6) and integrin ανβ6 play significant roles in accumulating mutations that drive the progression and metastatic capacities of cancer. The aim of...
6.
Li Z, Biswas S, Liang B, Zou X, Shan L, Li Y, et al.
Sci Rep
. 2016 Jul;
6:30081.
PMID: 27440504
Cholangiocarcinoma is a devastating malignancy that is notoriously difficult to diagnose and is associated with a high mortality. Despite extensive efforts to improve the diagnosis and treatment of this neoplasm,...
7.
Wang Z, Xu Z, Niu Z, Liang B, Niu J
Cell Biochem Biophys
. 2016 Jun;
73(2):559-564.
PMID: 27352353
Colorectal cancer is one of the most commonly diagnosed cancers in the world. Currently, drug resistance of cancer cell to chemotherapy is a major cause for cancer recurrence and death...
8.
Liang B, Shahbaz M, Wang Y, Gao H, Fang R, Niu Z, et al.
Clin Cancer Res
. 2015 Jan;
21(5):1183-95.
PMID: 25549721
Purpose: Adjuvant chemotherapy is one of the significant treatments for colon cancer in clinic. However, it does not achieve the desired therapeutic efficacy, largely due to chemotherapeutic resistance. Integrinβ6 (ITGB6)...
9.
Sun Q, Sun F, Wang B, Liu S, Niu W, Liu E, et al.
Cancer Lett
. 2014 Aug;
354(2):245-53.
PMID: 25150782
Colorectal cancer (CRC), which is notorious for high morbidity and mortality around the world, shows a predilection for metastasis to liver. Interleukin-8 (IL-8), a chemokine with a defining CXC amino...
10.
Gao H, Peng C, Liang B, Shahbaz M, Liu S, Wang B, et al.
Cancer Lett
. 2014 Aug;
354(2):427-37.
PMID: 25135220
We previously reported that β6 integrin played an important role in the progression of colon cancer. In this study, we demonstrated that β6 integrin induced the expression of MMP-3/MMP-9 and...